RXRX Exercise Disclosure
Hershberg Robert · SEC Form 4 · Filed Oct 7, 2026
Exercise
Calculated transaction value
$55.5K
Hershberg Robert Director
RXRX
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
RXRX daily price context
Close on/before transaction
$4.63
Oct 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Class A Common Stock
- Quantity / price
- 25,000 shares @ $2.22
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001601830-26-000119
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$236K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Exercise | Oct 6, 2026 | $55.5K |
| Recursion Pharmaceuticals, Inc. RXRX | Exercise | Oct 6, 2026 | $55.5K |
| Recursion Pharmaceuticals, Inc. RXRX | Sale | Oct 6, 2026 | $125K |